Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.500
+0.030 (2.04%)
At close: Jul 8, 2025, 4:00 PM
1.520
+0.020 (1.33%)
After-hours: Jul 8, 2025, 7:59 PM EDT
PACB Market Cap
PACB has a market cap or net worth of $450.13 million as of July 8, 2025. Its market cap has increased by 0.47% in one year.
Market Cap
450.13M
Enterprise Value
809.13M
1-Year Change
0.47%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since October 27, 2010, PACB's market cap has decreased from $823.90M to $450.13M, a decrease of -45.37%. That is a compound annual growth rate of -4.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 441.10M | -11.99% |
| Dec 31, 2024 | 501.20M | -80.90% |
| Dec 29, 2023 | 2.62B | 41.85% |
| Dec 30, 2022 | 1.85B | -59.02% |
| Dec 31, 2021 | 4.51B | -3.45% |
| Dec 31, 2020 | 4.67B | 494.29% |
| Dec 31, 2019 | 786.60M | -28.61% |
| Dec 31, 2018 | 1.10B | 259.04% |
| Dec 29, 2017 | 306.90M | -12.84% |
| Dec 30, 2016 | 352.10M | -65.19% |
| Dec 31, 2015 | 1.01B | 80.82% |
| Dec 31, 2014 | 559.40M | 61.68% |
| Dec 31, 2013 | 346.00M | 262.30% |
| Dec 31, 2012 | 95.50M | -37.79% |
| Dec 30, 2011 | 153.50M | -81.73% |
| Dec 31, 2010 | 840.40M | 2.00% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.11B |
| Johnson & Johnson | 373.81B |
| AbbVie | 333.14B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 274.75B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 231.66B |
| AstraZeneca | 218.65B |